Prolonged administration over six hours of large doses of intravenous iron saccharate (500 mg) prevents severe adverse reactions in peritoneal dialysis patients

MeSH terms

• Adult
• Aged
• Aged, 80 and over
• Anemia, Iron-Deficiency / etiology*
• Anemia, Iron-Deficiency / prevention & control*
• Dose-Response Relationship, Drug
• Drug Administration Schedule
• Drug Hypersensitivity / etiology*
• Drug Hypersensitivity / prevention & control*
• Female
• Humans
• Iron / administration & dosage*
• Iron / adverse effects
• Iron / therapeutic use*
• Kidney Diseases / therapy*
• Male
• Middle Aged
• Peritoneal Dialysis / adverse effects*
• Pharmaceutical Vehicles / administration & dosage*
• Pharmaceutical Vehicles / adverse effects
• Pharmaceutical Vehicles / therapeutic use*
• Time Factors